226 related articles for article (PubMed ID: 34229668)
1. Importance of hematological parameters for micro- and macrovascular outcomes in patients with type 2 diabetes: the Rio de Janeiro type 2 diabetes cohort study.
Cardoso CRL; Leite NC; Salles GF
Cardiovasc Diabetol; 2021 Jul; 20(1):133. PubMed ID: 34229668
[TBL] [Abstract][Full Text] [Related]
2. Prognostic importance of visit-to-visit blood pressure variability for micro- and macrovascular outcomes in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study.
Cardoso CRL; Leite NC; Salles GF
Cardiovasc Diabetol; 2020 May; 19(1):50. PubMed ID: 32359350
[TBL] [Abstract][Full Text] [Related]
3. Long-term visit-to-visit glycemic variability as predictor of micro- and macrovascular complications in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study.
Cardoso CRL; Leite NC; Moram CBM; Salles GF
Cardiovasc Diabetol; 2018 Feb; 17(1):33. PubMed ID: 29477146
[TBL] [Abstract][Full Text] [Related]
4. Prognostic impact of carotid intima-media thickness and carotid plaques on the development of micro- and macrovascular complications in individuals with type 2 diabetes: the Rio de Janeiro type 2 diabetes cohort study.
Cardoso CRL; Salles GC; Leite NC; Salles GF
Cardiovasc Diabetol; 2019 Jan; 18(1):2. PubMed ID: 30630491
[TBL] [Abstract][Full Text] [Related]
5. Prognostic impact of short-term ambulatory blood pressure variability for microvascular and macrovascular outcomes in patients with type 2 diabetes: the Rio de Janeiro Type 2 Diabetes Cohort Study.
Cardoso CRL; Salles GC; Leite NC; Salles GF
J Hypertens; 2021 May; 39(5):935-946. PubMed ID: 33239549
[TBL] [Abstract][Full Text] [Related]
6. Association of the systemic immuno-inflammation index, neutrophil-to-lymphocyte ratio, and platelet-to-lymphocyte ratio with diabetic microvascular complications.
Li J; Wang X; Jia W; Wang K; Wang W; Diao W; Ou F; Ma J; Yang Y
Front Endocrinol (Lausanne); 2024; 15():1367376. PubMed ID: 38660516
[TBL] [Abstract][Full Text] [Related]
7. Prognostic impact of liver fibrosis and steatosis by transient elastography for cardiovascular and mortality outcomes in individuals with nonalcoholic fatty liver disease and type 2 diabetes: the Rio de Janeiro Cohort Study.
Cardoso CRL; Villela-Nogueira CA; Leite NC; Salles GF
Cardiovasc Diabetol; 2021 Sep; 20(1):193. PubMed ID: 34560854
[TBL] [Abstract][Full Text] [Related]
8. Microvascular complications burden (nephropathy, retinopathy and peripheral polyneuropathy) affects risk of major vascular events and all-cause mortality in type 1 diabetes: a 10-year follow-up study.
Garofolo M; Gualdani E; Giannarelli R; Aragona M; Campi F; Lucchesi D; Daniele G; Miccoli R; Francesconi P; Del Prato S; Penno G
Cardiovasc Diabetol; 2019 Nov; 18(1):159. PubMed ID: 31733651
[TBL] [Abstract][Full Text] [Related]
9. Prognostic impact of the ankle-brachial index on the development of micro- and macrovascular complications in individuals with type 2 diabetes: the Rio de Janeiro Type 2 Diabetes Cohort Study.
Cardoso CRL; Melo JV; Salles GC; Leite NC; Salles GF
Diabetologia; 2018 Nov; 61(11):2266-2276. PubMed ID: 30112690
[TBL] [Abstract][Full Text] [Related]
10. Circulating amino acids and the risk of macrovascular, microvascular and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE trial.
Welsh P; Rankin N; Li Q; Mark PB; Würtz P; Ala-Korpela M; Marre M; Poulter N; Hamet P; Chalmers J; Woodward M; Sattar N
Diabetologia; 2018 Jul; 61(7):1581-1591. PubMed ID: 29728717
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for the development of micro-vascular complications of type 2 diabetes in a single-centre cohort of patients.
Teliti M; Cogni G; Sacchi L; Dagliati A; Marini S; Tibollo V; De Cata P; Bellazzi R; Chiovato L
Diab Vasc Dis Res; 2018 Sep; 15(5):424-432. PubMed ID: 29911415
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Importance of C-Reactive Protein in High Cardiovascular Risk Patients With Type 2 Diabetes Mellitus: The Rio de Janeiro Type 2 Diabetes Cohort Study.
Cardoso CR; Leite NC; Salles GF
J Am Heart Assoc; 2016 Oct; 5(11):. PubMed ID: 27912211
[TBL] [Abstract][Full Text] [Related]
13. Comparative predictive ability of visit-to-visit HbA1c variability measures for microvascular disease risk in type 2 diabetes.
Yang CY; Su PF; Hung JY; Ou HT; Kuo S
Cardiovasc Diabetol; 2020 Jul; 19(1):105. PubMed ID: 32631323
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Importance of Resistant Hypertension in Patients With Type 2 Diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study.
Cardoso CRL; Leite NC; Bacan G; Ataíde DS; Gorgonio LKC; Salles GF
Diabetes Care; 2020 Jan; 43(1):219-227. PubMed ID: 31619394
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Impact of On-Treatment Cumulative Ambulatory Blood Pressures for Adverse Macro- and Microvascular Outcomes in Individuals With Type 2 Diabetes: The Rio de Janeiro Type 2 Diabetes Cohort.
Cardoso CRL; Leite NC; Salles GF
Hypertension; 2023 Oct; 80(10):2178-2186. PubMed ID: 37548035
[TBL] [Abstract][Full Text] [Related]
16. Sex differences in the association of prediabetes and type 2 diabetes with microvascular complications and function: The Maastricht Study.
de Ritter R; Sep SJS; van der Kallen CJH; van Greevenbroek MMJ; de Jong M; Vos RC; Bots ML; Reulen JPH; Houben AJHM; Webers CAB; Berendschot TTJM; Dagnelie PC; Eussen SJPM; Schram MT; Koster A; Peters SAE; Stehouwer CDA
Cardiovasc Diabetol; 2021 May; 20(1):102. PubMed ID: 33962619
[TBL] [Abstract][Full Text] [Related]
17. Plasma thrombomodulin: a marker for microvascular complications in diabetes mellitus.
Gabat S; Keller C; Kempe HP; Amiral J; Ziegler R; Ritz E; Bergis KH; Wahl P; Nawroth P
Vasa; 1996; 25(3):233-41. PubMed ID: 8795304
[TBL] [Abstract][Full Text] [Related]
18. Eye complications and markers of morbidity and mortality in long-term type 1 diabetes.
Grauslund J
Acta Ophthalmol; 2011 Feb; 89 Thesis 1():1-19. PubMed ID: 21443578
[TBL] [Abstract][Full Text] [Related]
19. Cause-specific mortality rates in patients with diabetes according to comorbid macro- and microvascular complications: BioBank Japan Cohort.
Yokomichi H; Nagai A; Hirata M; Mochizuki M; Kojima R; Yamagata Z;
Endocrinol Diabetes Metab; 2021 Jan; 4(1):e00181. PubMed ID: 33532618
[TBL] [Abstract][Full Text] [Related]
20. Effect of duration and burden of microvascular complications on mortality rate in type 1 diabetes: an observational clinical cohort study.
Bjerg L; Hulman A; Carstensen B; Charles M; Witte DR; Jørgensen ME
Diabetologia; 2019 Apr; 62(4):633-643. PubMed ID: 30649599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
